Antithrombotic therapy has no benefit for low-risk atrial fibrillation patients
Findings from a large, community-based study show that antithrombotic therapy doesn’t decrease low-risk atrial fibrillation patients’ risk of suffering a stroke within five years. In fact, researchers found that low-risk patients fared better without any antithrombotic therapy. The new findings was from researchers at the Intermountain Medical Center Heart Institute in Salt Lake City. Antithrombotic […]
